Pituitary ACTH Hypersecretion
"Pituitary ACTH Hypersecretion" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A disease of the PITUITARY GLAND characterized by the excess amount of ADRENOCORTICOTROPIC HORMONE secreted. This leads to hypersecretion of cortisol (HYDROCORTISONE) by the ADRENAL GLANDS resulting in CUSHING SYNDROME.
| Descriptor ID |
D047748
|
| MeSH Number(s) |
C10.228.140.617.738.250.725 C19.700.355.800
|
| Concept/Terms |
Pituitary ACTH Hypersecretion- Pituitary ACTH Hypersecretion
- ACTH Hypersecretion, Pituitary
- Hypersecretion, Pituitary ACTH
- Cushing Disease, Pituitary
- Cushing Diseases, Pituitary
- Pituitary Cushing Disease
- Pituitary Cushing Diseases
- Pituitary-Dependant Hypercortisolism Disorder
- Hypercortisolism Disorder, Pituitary-Dependant
- Hypercortisolism Disorders, Pituitary-Dependant
- Pituitary Dependant Hypercortisolism Disorder
- Pituitary-Dependant Hypercortisolism Disorders
- Pituitary-Dependant Cushing Syndrome
- Cushing Syndrome, Pituitary-Dependant
- Pituitary Dependant Cushing Syndrome
- Pituitary-Dependant Hypercortisolism
- Hypercortisolism, Pituitary-Dependant
- Hypercortisolisms, Pituitary-Dependant
- Pituitary Dependant Hypercortisolism
- Pituitary-Dependant Hypercortisolisms
- Cushing Disease
- Disease, Cushing
- Pituitary Cushing Syndrome
- Cushing Syndrome, Pituitary
|
Below are MeSH descriptors whose meaning is more general than "Pituitary ACTH Hypersecretion".
Below are MeSH descriptors whose meaning is more specific than "Pituitary ACTH Hypersecretion".
This graph shows the total number of publications written about "Pituitary ACTH Hypersecretion" by people in this website by year, and whether "Pituitary ACTH Hypersecretion" was a major or minor topic of these publications.
View timeline visualization
| Year | Major Topic | Minor Topic | Total |
|---|
| 2004 | 2 | 0 | 2 |
| 2005 | 3 | 0 | 3 |
| 2006 | 1 | 0 | 1 |
| 2007 | 2 | 0 | 2 |
| 2008 | 3 | 1 | 4 |
| 2009 | 4 | 1 | 5 |
| 2010 | 5 | 2 | 7 |
| 2011 | 1 | 3 | 4 |
| 2012 | 3 | 0 | 3 |
| 2013 | 1 | 1 | 2 |
| 2014 | 1 | 0 | 1 |
| 2015 | 11 | 0 | 11 |
| 2016 | 1 | 0 | 1 |
| 2017 | 8 | 1 | 9 |
| 2018 | 3 | 0 | 3 |
| 2019 | 7 | 0 | 7 |
| 2020 | 2 | 1 | 3 |
| 2021 | 4 | 2 | 6 |
| 2022 | 4 | 0 | 4 |
| 2023 | 5 | 0 | 5 |
| 2024 | 2 | 0 | 2 |
Below are the most recent publications written about "Pituitary ACTH Hypersecretion" by people in Profiles.
-
Predictors of Durable Remission After Successful Surgery for Cushing Disease: Results From the Multicenter RAPID Registry. Neurosurgery. 2024 Oct 01; 95(4):761-769.
-
Multicenter Registry of Adenomas of the Pituitary and Related Disorders: Initial Description of Cushing Disease Cohort, Surgical Outcomes, and Surgeon Characteristics. Neurosurgery. 2024 Aug 01; 95(2):372-379.
-
Commentary: Endoscopic Endonasal Transsphenoidal Resection for MRI-Negative Cushing Disease With 2 Separate Functioning Pituitary Adenomas Neuroendocrine Tumors: 2-Dimensional Operative Video. Oper Neurosurg (Hagerstown). 2024 Feb 01; 26(2):245.
-
Long-term efficacy and safety of osilodrostat in patients with Cushing's disease: results from the LINC 4 study extension. Front Endocrinol (Lausanne). 2023; 14:1236465.
-
Angiographic cross-filling between inferior petrosal sinuses and alteration of adrenocorticotropic hormone sampling results for tumor localization in Cushing disease. J Neurosurg. 2024 Feb 01; 140(2):386-392.
-
An individualized approach to the management of Cushing disease. Nat Rev Endocrinol. 2023 10; 19(10):581-599.
-
Clinical features of muscle stiffness in 37 dogs with concurrent naturally occurring hypercortisolism. J Vet Intern Med. 2023 Mar; 37(2):578-585.
-
Treatment of Cushing Disease With Pituitary-Targeting Seliciclib. J Clin Endocrinol Metab. 2023 02 15; 108(3):726-735.
-
Levoketoconazole treatment in endogenous Cushing's syndrome: extended evaluation of clinical, biochemical, and radiologic outcomes. Eur J Endocrinol. 2022 Dec 01; 187(6):859-871.
-
Is E2F1 a Potential Medical Therapy Target for Cushing Disease? Endocrinology. 2022 09 01; 163(9).